Edding Genor Group Holdings Limited (HKG:6998)
Hong Kong · Delayed Price · Currency is HKD 3.040
+0.010 (0.33%)
Feb 13, 2026, 4:08 PM HKT
HKG:6998 Revenue
Edding Genor Group Holdings had revenue of 32.25M CNY in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 224.00M, up 1,448.06% year-over-year. In the year 2024, Edding Genor Group Holdings had annual revenue of 206.23M.
Revenue (ttm)
224.00M CNY
Revenue Growth
+1,448.06%
P/S Ratio
n/a
Revenue / Employee
13.18M CNY
Employees
17
Market Cap
6.09B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 206.23M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 15.93M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 10.33M | -2.71M | -20.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Traditional Chinese Medicine Holdings Co. | 17.08B |
| Shandong Xinhua Pharmaceutical Company | 9.28B |
| Luye Pharma Group | 6.76B |
| SSY Group | 4.58B |
| China Shineway Pharmaceutical Group | 3.66B |
| Beijing Tong Ren Tang Chinese Medicine Company | 1.71B |
| Jacobson Pharma Corporation | 1.53B |
| CanSino Biologics | 1.06B |